2 September 2026 Biologics psoriatic arthritis Research Oral TYK2 inhibitor holds PsA gains to one year
22 July 2026 Clinical research Obesity psoriatic arthritis Higher BMI may blunt TNF inhibitor response in PsA
24 June 2026 Biologics psoriatic arthritis Bimekizumab outperforms risankizumab in head-to-head PsA trial
6 August 2025 psoriatic arthritis Research Zasocitinib shows promise in psoriatic arthritis phase 2b trial
4 October 2023 Patients Psoriasis psoriatic arthritis Psoriasis management resources to empower your patients
22 March 2023 Pharmaceuticals Psoriasis psoriatic arthritis IL-23 inhibitors for psoriasis best at preventing arthritis development
20 June 2022 Arthritis COVID-19 Psoriasis psoriatic arthritis Rituximab and non-white ethnicity linked with worse covid outcomes
10 April 2022 Psoriasis psoriatic arthritis Psoriatic arthritis patients may need more than methotrexate
